Scientists say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals‘ lifespan.
Quelle: ScienceDaily | Immune System
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- The mechanism behind melanoma resistance to treatment
- Master autoimmune regulator gets by with a little help from its friends
- Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors
- Microrobot-packed pill shows promise for treating inflammatory bowel disease in mice
- A method to study immune cells offers hope for finding new disease treatments
- A new method for improving checkpoint inhibitor therapy for cancer
- Treatment for autoimmune disorder acts on balance of immune cell types
- Discovery of 'new rules of the immune system' could improve treatment of inflammatory diseases, say scientists
- Sepsis patients could get the right treatment faster, based on their genes
- Scientists solve decades long mystery of NLRC5 sensor function in cell death
